Advertisement

Topics

Novartis granted EU approval for first-line use of Zykadia

03:53 EDT 5 Jul 2017 | SmartBrief

Novartis' Zykadia, or ceritinib, has received expanded approval from the European Commission as a first-line treatment of pat -More

Original Article: Novartis granted EU approval for first-line use of Zykadia

NEXT ARTICLE

More From BioPortfolio on "Novartis granted EU approval for first-line use of Zykadia"

Quick Search
Advertisement
 

Relevant Topic

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...